Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 16 images provide visual information about the product associated with Pregabalin NDC 80425-0307 by Advanced Rx Pharmacy Of Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Description - Description

Formula - Formula

This is a formula for calculating a patient's estimated weight based on their age and weight in kilograms. The second line suggests that there may be an adjustment for female patients.*

label 1 - Pregabalin 25mg 80425 0307 01

This is a description of Pregabalin 25mg Capsule, a medication used for treating neuropathic pain, fibromyalgia, and generalized anxiety disorder. The medication is available in a bottle of 30 capsules and can be stored at a temperature ranging from 20-25 degrees Celsius. It is identical to Lyrica, and its NDC number is 0425-0307-01. The LOT number is X00000K, and its expiry date is 30th March 2023.*

label 2 - Pregabalin 25mg 80425 0307 02

This is a description of Pregabalin 25mg capsules, a medication that can be compared to LYRica. The lot number is X0KK and it expires on August 30, 2024. The rest of the text is not readable and contains non-English characters.*

label 3 - Pregabalin 25mg 80425 0307 03

This is a description of a medication sold at Store 025G (00T). The medication is Pregabalin 25mg Capsule, and there are 90 capsules in the container. The drug's NDC source is 60505-3793-09, and its NOC is 80435-0307-03. The expiration date is 9/30/2024. There is no further information available.*

fig 1 - fig 1

This is a chart showing the percentage of patients who improved after taking different doses of Pregabalin or a placebo. The percentages range from 0 to 100, with the highest percentage indicating the greatest improvement. There is no further information available to provide more context for the chart.*

fig 10 - fig 10

fig 11 - fig 11

fig 12 - fig 12

fig 2 - fig 2

fig 3 - fig 3

fig 4 - fig 4

fig 6 - fig 6

fig 7 - fig 7

This text contains statistical data and mentions p-values. The values shown suggest that the data is statistically significant. The rest of the text is not clear, but it seems to show data for different groups or treatments. Overall, it appears to be a statistical report or analysis.*

fig 9 - fig 9

This is a chart displaying the percentage of patients who improved based on different doses of Pragabalin and a placebo. The chart also shows the percentage improvement in pain from baseline.*

fig 5 - fig5

This appears to be a table showing the effectiveness of Pregabalin (at two different doses) compared to a placebo in treating pain, based on the percentage of patients who reported improvement at different levels. The table also includes dosage information (100mg and 50mg taken three times a day).*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.